222
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Does Consensus Equal Correctness?

&
Pages 689-690 | Published online: 18 Dec 2000

REFERENCES

  • Juurlink D N, McGuigan M A. Gastrointestinal decontamination for enteric-coated asprin overdose: What to do depends on who you ask. J Toxicol Clin Toxicol 2000; 38: 465–470
  • American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement: Ipecac syrup. J Toxicol Clin Toxicol 1997; 35: 699–709
  • American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement: Gastric lavage. J Toxicol Clin Toxicol 1997; 35: 711–719
  • American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement: Single-dose activated charcoal. J Toxicol Clin Toxicol 1997; 35: 721–741
  • American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement: Whole bowel irrigation. J Toxicol Clin Toxicol 1997; 35: 753–762
  • American Academy of Clinical Toxicology/European Association of Poisons Centres and Clinical Toxicologists. Position statement and practice guidelines on the use of multi-dose activated charcoal in the treatment of acute poisoning. J Toxicol Clin Toxicol 1999; 37: 731–751
  • Kulig K, Bar-Or D, Cantrill S V, Rosen P, Rumack B H. Management of acutely poisoned patients without gastric emptying. Ann Emerg Med 1985; 14: 562–567
  • Merigian K S, Woodard M, Hedges J R, et al. Prospective evaluation of gastric emptying in the self-poisoned patient. Am J Emerg Med 1990; 8: 479–483
  • Pond S M, Lewis-Driver D J, Williams G M, Green A C, Stevenson N W. Gastric emptying in acute overdose: A prospective randomised controlled trial. Med J Aust 1995; 163: 345–349
  • Kirshenbaum L A, Mathews S C, Sitar D S, Tenenbein M. Whole-bowel irrigation versus activated charcoal in sorbitol for the ingestion of modified-release pharmaceuticals. Clin Pharmacol Ther 1989; 46: 264–271

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.